- US-listed companies
- NORTHWEST BIOTHERAPEUTICS INC
- Balance sheet
NORTHWEST BIOTHERAPEUTICS INCNWBO
Market cap
$345.05M
P/E ratio
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 18 | 13 | 22 | 6 | 0 | 22 | 0 | 10 | 15 | 7 | 2 | 2 |
| Total cash & short-term investments | 18 | 13 | 22 | 6 | 0 | 22 | 0 | 10 | 15 | 7 | 2 | 2 |
| Total current assets | 19 | 15 | 24 | 8 | 1 | 24 | 3 | 16 | 17 | 9 | 4 | 4 |
| Property, plant and equipment, net | 0 | 40 | 46 | 0 | 0 | 0 | 0 | 1 | 15 | 13 | 17 | 16 |
| Total non-current assets | 0 | 44 | 47 | 45 | 48 | 1 | 6 | 17 | 23 | 22 | 24 | 23 |
| Total assets | 19 | 58 | 71 | 53 | 49 | 25 | 9 | 33 | 40 | 31 | 28 | 27 |
| Accounts payable | 9 | 16 | 12 | 12 | - | - | - | - | - | - | - | - |
| Total current liabilities | 20 | 69 | 65 | 76 | 88 | 70 | 41 | 382 | 134 | 126 | 45 | 68 |
| Total non-current liabilities | - | 25 | 11 | 3 | 9 | 2 | 12 | 13 | 30 | 10 | 30 | 37 |
| Total liabilities | 20 | 93 | 75 | 79 | 96 | 72 | 53 | 396 | 164 | 136 | 75 | 106 |
| Common stock and paid-in capital | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | - | - | - | - | - | -824 | -840 | -1,371 | -1,192 | -1,297 | -1,360 | -1,443 |
| Stockholders' equity | -10 | -35 | -5 | -26 | -67 | -47 | -44 | -363 | -124 | -128 | -66 | -94 |